Missed Opportunity
The United States-Mexico-Canada Agreement has been approved by both the U.S. House of Representatives and Senate, clearing the way to replace the defunct North American Free Trade Agreement of 1993. But the deal completely omitted expanded protection for biologic drugs.
Read More